A statistical model to predict one-year risk of death in patients with cystic fibrosis
- PMID:25655532
- DOI: 10.1016/j.jclinepi.2014.12.010
A statistical model to predict one-year risk of death in patients with cystic fibrosis
Abstract
Objectives: We constructed a statistical model to assess the risk of death for cystic fibrosis (CF) patients between scheduled annual clinical visits. Our model includes a CF health index that shows the influence of risk factors on CF chronic health and on the severity and frequency of CF exacerbations.
Study design and setting: Our study used Canadian CF registry data for 3,794 CF patients born after 1970. Data up to 2010 were analyzed, yielding 44,390 annual visit records. Our stochastic process model postulates that CF health between annual clinical visits is a superposition of chronic disease progression and an exacerbation shock stream. Death occurs when an exacerbation carries CF health across a critical threshold. The data constitute censored survival data, and hence, threshold regression was used to connect CF death to study covariates. Maximum likelihood estimates were used to determine which clinical covariates were included within the regression functions for both CF chronic health and CF exacerbations.
Results: Lung function, Pseudomonas aeruginosa infection, CF-related diabetes, weight deficiency, pancreatic insufficiency, and the deltaF508 homozygous mutation were significantly associated with CF chronic health status. Lung function, age, gender, age at CF diagnosis, P aeruginosa infection, body mass index <18.5, number of previous hospitalizations for CF exacerbations in the preceding year, and decline in forced expiratory volume in 1 second in the preceding year were significantly associated with CF exacerbations. When combined in one summative model, the regression functions for CF chronic health and CF exacerbation risk provided a simple clinical scoring tool for assessing 1-year risk of death for an individual CF patient. Goodness-of-fit tests of the model showed very encouraging results. We confirmed predictive validity of the model by comparing actual and estimated deaths in repeated hold-out samples from the data set and showed excellent agreement between estimated and actual mortality.
Conclusion: Our threshold regression model incorporates a composite CF chronic health status index and an exacerbation risk index to produce an accurate clinical scoring tool for prediction of 1-year survival of CF patients. Our tool can be used by clinicians to decide on optimal timing for lung transplant referral.
Keywords: Cystic fibrosis; Health index; Mortality; Registry data; Risk scoring tool; Threshold regression.
Copyright © 2015 Elsevier Inc. All rights reserved.
Similar articles
- Development and external validation of 1- and 2-year mortality prediction models in cystic fibrosis.Stanojevic S, Sykes J, Stephenson AL, Aaron SD, Whitmore GA.Stanojevic S, et al.Eur Respir J. 2019 Sep 5;54(3):1900224. doi: 10.1183/13993003.00224-2019. Print 2019 Sep.Eur Respir J. 2019.PMID:31097523
- Chronic Stenotrophomonas maltophilia infection and mortality or lung transplantation in cystic fibrosis patients.Waters V, Atenafu EG, Lu A, Yau Y, Tullis E, Ratjen F.Waters V, et al.J Cyst Fibros. 2013 Sep;12(5):482-6. doi: 10.1016/j.jcf.2012.12.006. Epub 2013 Jan 5.J Cyst Fibros. 2013.PMID:23294530
- Exacerbation frequency and clinical outcomes in adult patients with cystic fibrosis.de Boer K, Vandemheen KL, Tullis E, Doucette S, Fergusson D, Freitag A, Paterson N, Jackson M, Lougheed MD, Kumar V, Aaron SD.de Boer K, et al.Thorax. 2011 Aug;66(8):680-5. doi: 10.1136/thx.2011.161117. Epub 2011 Jun 15.Thorax. 2011.PMID:21680566
- The clinical presentations of pulmonary aspergillosis in children with cystic fibrosis - preliminary report.Walicka-Serzysko K, Sands D.Walicka-Serzysko K, et al.Dev Period Med. 2015 Jan-Mar;19(1):66-79.Dev Period Med. 2015.PMID:26003072
- Survival in Cystic Fibrosis: Trends, Clinical Factors, and Prediction Models.Chin M, Earlam K, Aaron SD.Chin M, et al.Pediatr Allergy Immunol Pulmonol. 2015 Dec;28(4):244-249. doi: 10.1089/ped.2015.0531. Epub 2015 Oct 8.Pediatr Allergy Immunol Pulmonol. 2015.PMID:35923000Review.
Cited by
- Development and Internal Validation of a Prognostic Model of the Probability of Death or Lung Transplantation Within 2 Years for Patients With Cystic Fibrosis and FEV1 ≤ 50% Predicted.Ramos KJ, Hee Wai T, Stephenson AL, Sykes J, Stanojevic S, Rodriguez PJ, Bansal A, Mayer-Hamblett N, Goss CH, Kapnadak SG.Ramos KJ, et al.Chest. 2022 Oct;162(4):757-767. doi: 10.1016/j.chest.2022.05.021. Epub 2022 May 26.Chest. 2022.PMID:35643116Free PMC article.
- Cardiopulmonary responses to maximal aerobic exercise in patients with cystic fibrosis.Williams CA, Wedgwood KCA, Mohammadi H, Prouse K, Tomlinson OW, Tsaneva-Atanasova K.Williams CA, et al.PLoS One. 2019 Feb 13;14(2):e0211219. doi: 10.1371/journal.pone.0211219. eCollection 2019.PLoS One. 2019.PMID:30759119Free PMC article.
- Use of FEV1 in cystic fibrosis epidemiologic studies and clinical trials: A statistical perspective for the clinical researcher.Szczesniak R, Heltshe SL, Stanojevic S, Mayer-Hamblett N.Szczesniak R, et al.J Cyst Fibros. 2017 May;16(3):318-326. doi: 10.1016/j.jcf.2017.01.002. Epub 2017 Jan 20.J Cyst Fibros. 2017.PMID:28117136Free PMC article.Review.
- The Dynamics of Disease Progression in Cystic Fibrosis.Adler FR, Liou TG.Adler FR, et al.PLoS One. 2016 Jun 1;11(6):e0156752. doi: 10.1371/journal.pone.0156752. eCollection 2016.PLoS One. 2016.PMID:27248696Free PMC article.
- Prognostication and Risk Factors for Cystic Fibrosis via Automated Machine Learning.Alaa AM, van der Schaar M.Alaa AM, et al.Sci Rep. 2018 Jul 26;8(1):11242. doi: 10.1038/s41598-018-29523-2.Sci Rep. 2018.PMID:30050169Free PMC article.
MeSH terms
Related information
LinkOut - more resources
Full Text Sources
Medical